Q2 2024 |
63 |
$1.65B |
+$47M |
-$528M |
-$481M |
KRYS, FOLD, NRIX, STOK, IMNM
|
13F-HR |
8/14/2024, 04:16 PM |
Q1 2024 |
76 |
$2.7B |
+$468M |
-$878M |
-$410M |
KRYS, FOLD, IMNM, SRRK, FATE
|
13F-HR |
5/15/2024, 04:50 PM |
Q4 2023 |
68 |
$2.79B |
+$465M |
-$319M |
+$146M |
IMGN, KRYS, FOLD, SRRK, RYZB
|
13F-HR |
2/14/2024, 04:16 PM |
Q3 2023 |
75 |
$2.1B |
+$137M |
-$372M |
-$235M |
IMGN, KRYS, FOLD, AKRO, AUGX
|
13F-HR |
11/14/2023, 04:15 PM |
Q2 2023 |
82 |
$2.61B |
+$487M |
-$443M |
+$43.5M |
IMGN, KRYS, FOLD, REPL, AKRO
|
13F-HR |
8/14/2023, 05:15 PM |
Q1 2023 |
76 |
$2.3B |
+$383M |
-$207M |
+$176M |
FOLD, KRYS, ISEE, DCPH, AKRO
|
13F-HR |
5/15/2023, 04:15 PM |
Q4 2022 |
69 |
$2.44B |
+$290M |
-$217M |
+$72.8M |
FOLD, KRYS, AKRO, REPL, FATE
|
13F-HR |
2/14/2023, 03:18 PM |
Q3 2022 |
70 |
$2.58B |
+$313M |
-$197M |
+$117M |
FATE, FOLD, KRYS, ARGX, PLRX
|
13F-HR |
11/14/2022, 03:03 PM |
Q2 2022 |
71 |
$2.62B |
+$296M |
-$100M |
+$196M |
FATE, FOLD, SGEN, ARGX, KRYS
|
13F-HR |
8/15/2022, 05:22 PM |
Q1 2022 |
70 |
$3.2B |
+$179M |
-$119M |
+$59.5M |
FATE, FOLD, ARGX, LIVN, KRYS
|
13F-HR |
5/16/2022, 04:13 PM |
Q4 2021 |
71 |
$4.4B |
+$449M |
-$636M |
-$187M |
FATE, FOLD, SNCE, ARGX, LIVN
|
13F-HR |
2/14/2022, 04:07 PM |
Q3 2021 |
75 |
$5.73B |
+$516M |
-$714M |
-$198M |
FATE, ALLK, IGMS, ARGX, ADCT
|
13F-HR |
11/15/2021, 04:16 PM |
Q2 2021 |
86 |
$6.76B |
+$476M |
-$812M |
-$336M |
FATE, IGMS, BEAM, ARGX, FOLD
|
13F-HR |
8/16/2021, 05:00 PM |
Q1 2021 |
86 |
$7.1B |
+$1.13B |
-$1.4B |
-$264M |
FATE, ALLK, IGMS, ARGX, FOLD
|
13F-HR |
5/17/2021, 04:05 PM |
Q4 2020 |
87 |
$8.26B |
+$1.61B |
-$274M |
+$1.34B |
FATE, FOLD, ALLK, BEAM, IGMS
|
13F-HR |
2/16/2021, 03:06 PM |
Q3 2020 |
80 |
$5.42B |
+$1.13B |
-$410M |
+$717M |
FATE, FOLD, IMMU, ARGX, IGMS
|
13F-HR |
11/16/2020, 03:09 PM |
Q2 2020 |
79 |
$5.31B |
+$1.37B |
-$502M |
+$867M |
FATE, FOLD, DCPH, ADCT, ARGX
|
13F-HR |
8/14/2020, 04:16 PM |
Q1 2020 |
69 |
$3.57B |
+$674M |
-$177M |
+$497M |
FATE, FOLD, DCPH, BIIB, IGMS
|
13F-HR |
5/15/2020, 04:04 PM |
Q4 2019 |
64 |
$4.18B |
+$1.11B |
-$227M |
+$888M |
DCPH, ALLK, FOLD, FATE, EPZM
|
13F-HR |
2/14/2020, 03:10 PM |
Q3 2019 |
74 |
$2.99B |
+$709M |
-$69.7M |
+$639M |
ALLK, FOLD, FATE, DCPH, ALDR
|
13F-HR |
11/14/2019, 03:11 PM |
Q2 2019 |
81 |
$3.53B |
+$605M |
-$295M |
+$310M |
ARRY, FOLD, FATE, ARGX, QURE
|
13F-HR |
8/14/2019, 04:04 PM |
Q1 2019 |
82 |
$3.42B |
+$662M |
-$215M |
+$447M |
ARRY, FOLD, FATE, ATRA, ARGX
|
Restatement |
5/17/2019, 08:56 PM |
Q4 2018 |
78 |
$2.49B |
+$373M |
-$193M |
+$180M |
ARRY, ATRA, FATE, XNCR, WVE
|
Restatement |
5/16/2019, 03:34 PM |
Q3 2018 |
83 |
$3.25B |
+$699M |
-$208M |
+$490M |
ARRY, ATRA, FATE, RGNX, XNCR
|
Restatement |
5/16/2019, 03:34 PM |
Q2 2018 |
81 |
$2.94B |
+$705M |
-$301M |
+$404M |
ARRY, FOLD, ATRA, IMGN, XNCR
|
13F-HR |
8/14/2018, 04:32 PM |
Q1 2018 |
64 |
$2.57B |
+$569M |
-$103M |
+$466M |
ARRY, ATRA, FOLD, IMGN, XNCR
|
13F-HR |
5/15/2018, 04:30 PM |
Q4 2017 |
1 |
$6.6M |
|
|
|
LIFE
|
New Holdings |
3/8/2018, 03:01 PM |
Q4 2017 |
70 |
$2.3B |
+$678M |
-$123M |
+$555M |
ARRY, FOLD, PBYI, CLVSQ, WVE
|
13F-HR |
2/14/2018, 04:03 PM |
Q3 2017 |
65 |
$2.03B |
+$628M |
-$177M |
+$451M |
ARRY, FOLD, PBYI, SGENXXXX, CLVSQ
|
13F-HR |
11/14/2017, 03:23 PM |
Q2 2017 |
64 |
$1.64B |
+$397M |
-$243M |
+$154M |
ARRY, FOLD, PEN, PBYI, CLVSQ
|
13F-HR |
8/14/2017, 05:39 PM |
Q1 2017 |
60 |
$1.54B |
+$489M |
-$195M |
+$295M |
ARRY, PEN, FOLD, PBYI, CLVSQ
|
13F-HR |
5/15/2017, 04:41 PM |
Q4 2016 |
50 |
$1.16B |
+$246M |
-$119M |
+$128M |
ARRY, SGENXXXX, CLVSQ, PEN, FOLD
|
13F-HR |
2/14/2017, 03:40 PM |
Q3 2016 |
51 |
$1.26B |
+$383M |
-$187M |
+$197M |
ARRY, SGENXXXX, FOLD, CLVSQ, GWPH
|
13F-HR |
11/14/2016, 05:26 PM |
Q2 2016 |
53 |
$1.03B |
+$245M |
-$177M |
+$67.9M |
ARRY, FOLD, MDVN, SGENXXXX, ATRA
|
13F-HR |
8/15/2016, 06:47 PM |
Q1 2016 |
47 |
$977M |
+$258M |
-$90.2M |
+$168M |
FOLD, MDVN, CLVSQ, PEN, ARRY
|
13F-HR |
5/16/2016, 05:22 PM |
Q4 2015 |
57 |
$1.34B |
+$406M |
-$141M |
+$264M |
FOLD, MDVN, PEN, ARRY, ITCI
|
13F-HR |
2/16/2016, 03:53 PM |
Q3 2015 |
58 |
$1.32B |
+$735M |
-$51.2M |
+$684M |
FOLD, CLVSQ, ARRY, MDVN, INCY
|
Restatement |
11/17/2015, 02:23 PM |
Q2 2015 |
55 |
$1.22B |
+$394M |
-$172M |
+$221M |
ARRY, FOLD, VRX, CLVSQ, TEVA
|
13F-HR |
8/14/2015, 04:27 PM |
Q1 2015 |
54 |
$1.11B |
+$435M |
-$117M |
+$317M |
ARRY, CLVSQ, FOLD, VRX, TEVA
|
13F-HR |
5/15/2015, 07:11 PM |
Q4 2014 |
54 |
$918M |
+$210M |
-$93.8M |
+$116M |
FOLD, ARRY, VRX, CMRX, RADXXXX
|
13F-HR |
2/17/2015, 06:28 PM |
Q3 2014 |
54 |
$866M |
+$368M |
-$135M |
+$232M |
VRX, B108PS, CLVSQ, CELG, FOLD
|
13F-HR |
11/14/2014, 03:29 PM |
Q2 2014 |
48 |
$825M |
+$336M |
-$114M |
+$222M |
B108PS, MDTXXXX, ARRY, UHS, HCA
|
13F-HR |
8/14/2014, 06:52 PM |
Q1 2014 |
55 |
$838M |
+$363M |
-$168M |
+$194M |
B108PS, HCA, A, VRX, CLVSQ
|
Restatement |
8/19/2014, 02:09 PM |
Q4 2013 |
55 |
$805M |
|
|
|
GILD, CLVSQ, ZBH, CELG, AZN
|
13F-HR |
2/14/2014, 04:16 PM |